Serological Thymidine Kinase 1 is a Biomarker for Early Detection of Tumours—A Health Screening Study on 35,365 People, Using a Sensitive Chemiluminescent Dot Blot Assay

Serological thymidine kinase 1 (STK1) is a reliable proliferation marker for prognosis, monitoring tumour therapy, and relapse. Here we investigated the use of STK1 in health screening for early detection of pre-malignant and malignant diseases. The investigation was based on 35,365 participants in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhi Heng, Huang, Shou Qing, Wang, Yande, Yang, Ai Zhen, Wen, Jian, Xu, Xiao Hong, Chen, Yan, Chen, Qu Bo, Wang, Ying Hong, He, Ellen, Zhou, Ji, Skog, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251970/
https://www.ncbi.nlm.nih.gov/pubmed/22247653
http://dx.doi.org/10.3390/s111211064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251970/
https://www.ncbi.nlm.nih.gov/pubmed/22247653
http://dx.doi.org/10.3390/s111211064

Ejemplares similares